Fibrosis: Clinical Trials

90 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

90 unknown. 90 Phase 2, 26 Phase 1, 16 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 290Unknown 90
Phase 126Unknown 26
Phase 316Unknown 16

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 90 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds
DERMASEAL - Skin Graft Complications
Phase 1 / Phase 2UnknownHobart W. Harris122024-09-012024-06-11
Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.
Insulin group, Botulinum toxin group, Triamcinolone acetonide group - Keloid
Phase 1 / Phase 2UnknownAssiut University452024-05-012024-01-30
Ethosomal Gel Bearing Losartan 5% for Keloid Treatment
Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml - Keloid
Phase 1 / Phase 2UnknownYuni Eka Anggraini462024-03-302023-12-05
Use of Botulinum Toxin A in Direct Eyebrow Lift Scar
Botulinum toxin type A - Skin Scarring, Eyebrow Ptosis
Phase 2UnknownUniversity of Sao Paulo402024-01-012024-06-18
Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars
siSPARC + siLR4A microneedle patches, siSPARC microneedle patch - Keloid, Wound Heal
Phase 2UnknownNational Skin Centre502023-11-142024-06-24
Treatment of Hypopigmented Scars With Bimatoprost
Bimatoprost, Saline - Scars, Hypopigmented Scar
Phase 2UnknownMedstar Health Research Institute252023-07-182024-05-03
Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver Cirrhosis
Polidocanol foam sclerotherapy - Hemorrhoids, Liver Cirrhosis
Phase 2 / Phase 3UnknownUniversidade do Porto402023-03-312023-04-11
Ointment to Prevent Scar After Thyroidectomy
INV-001 - Scar
Phase 2UnknownInnovo Therapeutics, Inc.752023-02-142023-05-03
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
Rencofilstat, Placebo - Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver
Phase 2UnknownHepion Pharmaceuticals, Inc.1202022-10-152024-05-03
Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19
Treamid, Treamid twice a day, Treamid once a day - SARS-CoV-2 Infection, Lung Fibrosis
Phase 2 / Phase 3UnknownPHARMENTERPRISES LLC4122022-08-012022-08-25
Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction
Dapagliflozin - Heart Failure, Reduced Ejection Fraction
Phase 2UnknownAssistance Publique - Hôpitaux de Paris402022-06-262022-12-09
RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Cudetaxestat (BLD-0409), Control: Matching Placebo - Idiopathic Pulmonary Fibrosis
Phase 2UnknownBlade Therapeutics2002022-05-312022-05-18
Liver Cancer Disparities in American Indian and Alaska Native Persons
Ultrasound or abbreviated MRI - Hepatocellular Carcinoma, Cirrhosis, Liver
Phase 2UnknownUniversity of Washington2002022-04-012024-06-04
Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN - Cirrhosis, Liver, Vaccination Failure
Phase 2UnknownCentral Hospital, Nancy, France602021-11-012021-08-31
A Single and Repeat Dose Trial in Participants With Hepatic Impairment
GB1211, Placebo - Hepatic Impairment
Phase 1 / Phase 2UnknownGalecto Biotech AB542021-09-092023-05-11
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
Dapagliflozin (10Mg Tab) along with standard medical therapy, Placebo of dapaglifozin along with standard medical therapy - Cirrhosis, Ascites Hepatic
Phase 2UnknownPost Graduate Institute of Medical Education and Research, Chandigarh442021-09-032021-09-05
Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)
UC-MSCs, Saline solution - Cirrhosis Due to Hepatitis B
Phase 1 / Phase 2UnknownRenmin Hospital of Wuhan University202021-07-202022-08-19
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
AXA1125, Placebo - Non Alcoholic Steatohepatitis (NASH)
Phase 2UnknownAxcella Health, Inc2732021-05-072022-09-08
Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids
Autologous Adipose Derived stem cell transplantation, Triamcinolone Acetonide 40Mg/Ml Inj,Susp_#1 - Adipose Derived Stem Cells, Keloid
Phase 2UnknownMakerere University302021-05-012021-06-18
The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19
MON002 - Pulmonary Fibrosis, Interstitial Lung Disease
Phase 1 / Phase 2UnknownGuy's and St Thomas' NHS Foundation Trust52021-03-082021-03-18

Showing 20 of 90. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (35)  ·  Cicatrix (12)  ·  Pulmonary Fibrosis (9)  ·  Cicatrix, Hypertrophic (6)  ·  Keloid (6)  ·  Ascites (5)  ·  Hypertension, Portal (5)  ·  COVID-19 (4)  ·  Liver Cirrhosis, Biliary (4)  ·  End Stage Liver Disease (3)  ·  Hepatitis C (3)  ·  Non-alcoholic Fatty Liver Disease (3)  ·  Breast Neoplasms (2)  ·  Hypertension, Pulmonary (2)

Broader conditions

Pathologic Processes (90)  ·  Pathological Conditions, Signs and Symptoms (90)  ·  Digestive System Diseases (44)  ·  Liver Diseases (43)  ·  Infections (10)  ·  Skin and Connective Tissue Diseases (10)  ·  Cicatrix (9)  ·  Lung Diseases (9)  ·  Respiratory Tract Diseases (9)  ·  Virus Diseases (9)  ·  Lung Diseases, Interstitial (8)  ·  RNA Virus Infections (8)  ·  Chronic Disease (6)  ·  Collagen Diseases (6)

Interventions

Rifaximin (3)  ·  Triamcinolone Acetonide (3)  ·  Botulinum Toxins, Type A (2)  ·  Hyperbaric Oxygenation (2)  ·  Probiotics (2)  ·  Propranolol (2)  ·  TGFB3 protein, human (2)  ·  dapagliflozin (2)  ·  pirfenidone (2)  ·  3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (1)  ·  Albumins (1)  ·  Bevacizumab (1)  ·  Bimatoprost (1)  ·  CRV-431 (1)  ·  Carvedilol (1)

Sponsors

Sun Yat-sen University (4)  ·  Air Force Military Medical University, China (3)  ·  Assiut University (2)  ·  Beijing 302 Hospital (2)  ·  Leiden University Medical Center (2)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  Renovo (2)  ·  University of Turin, Italy (2)  ·  Yonsei University (2)  ·  Alexandria University (1)  ·  All India Institute of Medical Sciences (1)  ·  Alliancells Bioscience Corporation Limited (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Axcella Health, Inc (1)  ·  Azienda Ospedaliera di Padova (1)

Countries

China (20)  ·  United States (13)  ·  United Kingdom (7)  ·  Italy (6)  ·  Brazil (4)  ·  India (4)  ·  Mexico (4)  ·  South Korea (4)  ·  Egypt (3)  ·  France (3)  ·  Netherlands (3)  ·  Canada (2)  ·  Iran (2)  ·  Singapore (2)  ·  Spain (2)

Top investigators

Daiming Fan (3)  ·  John R. Yarnold, MD, FRCR (2)  ·  Stephen Harrison, MD (2)  ·  Aldar Bourinbaiar, MD/PhD (1)  ·  Anthony Papp, MD, PhD (1)  ·  Ashika Ahmed, MD (1)  ·  Ashish Patel, PhD FRCS (1)  ·  Bijan Modarai, PhD FRCS (1)  ·  Bingliang Lin, MD (1)  ·  Bruno SF Souza, MD, Msc (1)  ·  Carlo Alessandria, MD (1)  ·  Carlo Buzio, MD (1)

Results publications

PMID 10415784, PMID 11807470, PMID 12563677, PMID 12877429, PMID 14719037, PMID 15001284, PMID 15119583, PMID 15663512, PMID 16009415, PMID 16393283, PMID 17181919, PMID 17262225, PMID 17288322, PMID 18097874, PMID 18228057, PMID 18666493, PMID 18717178, PMID 19295939, PMID 19397687, PMID 19411519, PMID 19453649, PMID 19830963, PMID 19998041, PMID 20005565, PMID 20978636, PMID 21131395, PMID 21701333, PMID 21733570, PMID 21741331, PMID 21762980, PMID 22028728, PMID 22545014, PMID 22731679, PMID 23349326, PMID 23747824, PMID 23782511, PMID 24004965, PMID 24473714, PMID 24876849, PMID 25491391, PMID 26006200, PMID 2682703, PMID 26867177, PMID 28316259, PMID 28584818, PMID 29467010, PMID 29499740, PMID 29799555, PMID 30473697, PMID 31784348

NIH funding

2009 (1), 2014 (1), 2015 (1), 272201800011C-P00005-9999-1 (1), P20CA252732 (1), U01DK111510 (1)